Zuora, Inc., a leading monetization platform for modern business, today announced that it has joined the SAP® PartnerEdge® program as a Build Partner. The SAP Integration and Certification Center (SAP ...

The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...

While the rates and timings of tariffs on the sector are unclear, analysts expect that companies will have to absorb any near ...

EPS estimates, maintains 2025 guidance, and targets $5.7 billion in cost savings through automation and R&D streamlining.

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and ...

Pfizer expects full-year earnings in the range of $2.80 to $3 per share, with revenue in the range of $61 billion to $64 billion. This story was generated by Automated Insights ( ...

high-risk NMIBC in over three decades,” said Megan O’Meara, M.D., interim chief development officer, Pfizer Oncology. “The CREST findings are especially impactful for these patients with early-stage ...